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Case Reportsinstitution and stabilized with femoral venoarterial extracor-
poreal membrane oxygenation. The patient was deemed
a transplant candidate and taken to the operating room 4
days later for mechanical circulatory support. Intraoperative
evaluation noted extensive bilateral myocardial necrosis and
friability, including the left apex, septum, and a large portion
of the right ventricle. The decision was made for TAH-t
placement. On postoperative days 0, 1, and 3, the patient re-
quired reexploration and evacuation of hematoma for bleed-
ing and mediastinal hematoma. She continued to progress to
multiorgan failure, coagulopathy, and vasodilatory shock
despite multipressor support. Evidence of sepsis, including
bilateral pneumonia and lactic acidosis, led to discontinu-
ance of support 9 days after TAH-t implantation.
DISCUSSION
VSDs are rare, life-threatening complications that occur
after MI in 1% to 2% of patients.1 As many as 90% of pa-
tients would die without intervention; however, mortality
with emergency surgical or percutaneous repair is still
greater than 50%.1 Patients who have cardiogenic shock
and biventricular failure develop requiremechanical support
for stabilization until definitive repair or transplant can be
performed. Implantable left ventricular assist devices have
been successfully used as a bridge to transplant after post-
MI VSD.3 Securing the inflow cannula to infarcted apical
myocardium can be technically difficult, and post-MI ven-
tricular arrhythmias may complicate left ventricular assist
device management. Severe valvular insufficiency and
post-MI extensive left ventricular myocardial loss with
poor function may favor replacement of both ventricles.
The TAH-t is a pneumatic, pulsatile pump that replaces
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e26 The Journal of Thoracic and Cardiovascular Surgthe TAH-t has been shown to improve outcomes in unstable
patients in end-stage cardiogenic shock by providing imme-
diate hemodynamic stabilization and end-organ perfusion
until cardiac transplant can occur. Survivals to transplant
with the TAH-t as great as 79% have been reported,4 com-
parable to biventricular support survival of 56% at 6
months.5 Use of the TAH-t currently obligates the patient
to undergo a transplant, and every effort should be made
to preserve the patient’s own myocardium. All mechanical
support devices possess inherent risk factors, including
infection, thromboembolism, and hemorrhage.
We present the first 2 cases of patients with post-MI VSD
rupture with end-stage cardiogenic shock to undergo TAH-t
placement. TAH-t support is an alternative option to biven-
tricular support devices for critically unstable patients with
post-MIVSDandextensiveventricularmyocardial loss.Mor-
talitywas 50% in this small series, which underlines the com-
plexity of predicting outcomes in this patient population.References
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Libman-Sacks endocarditisNaritomo Nishioka, MD, Naoto Morimoto, MD, PhD, Masato Yoshida, MD, PhD, and
Nobuhiko Mukohara, MD, PhD, Himeji-city, JapanLibman-Sacks endocarditis, first described by Libman and
Sacks1 in 1924, is the pathognomonic valvular lesion of sys-
temic lupus erythematosus or antiphospholipid antibody syn-
drome that may develop on the endocardial surface of the
heart. These lesions have a propensity toward formation on
the left valves, particularly the ventricular surface of the mi-
tral valve.We report the case of a 26-year-oldwomanwithout
a history of cardiac diseasewhowas seen for an atypical form
of Libman-Sacks endocarditis. The disease progressed in anery c February 2013
FIGURE 1. Echocardiography showed vegetations confined to the left ventricle.
Case Reportsunusually aggressive manner, with large vegetation forma-
tion in the left ventricular cavity. The cardiac valves func-
tioned normally and were not affected by the disease.
CLINICAL SUMMARY
A 26-year-old woman was seen with multiple intracavitary
left ventricularmasses andcongestive heart failure.Onemonth
previously, she had been seenwith hematuria, low-grade fever,
and development of renal failure and dyspnea on exertion.
After the patient’s admission, fever, anuria, and hypoten-
sion were noted, in conjunction with increases in the
serum levels of creatinine (2.7 mg/dL), creatine kinase
(7012 IU/L), total bilirubin (2.8 g/dL), aspartate amino-
transferase (3359 IU/L), alanine aminotransferase (973
IU/L), and C-reactive protein (7.0 mg/dL) and a prolonga-
tion of prothrombin time (international normalized ratio
of 2.75). Transthoracic echocardiography showed a left
ventricular ejection fraction of 20% with diffuse hypokine-
sia and normal valves. Multiple mobile isoechoic mass le-
sions ranging from 2 to 5 cm were noted at the apex of
the left ventricle (Figure 1). Inotropic support, continuous
hemofiltration, and systemic anticoagulation with heparin
were initiated in response to the suspicion of acute myocar-
ditis complicated by left ventricular thrombus. Results of
repeated blood cultures were negative, and there was noThe Journal of Thoracic and Caevidence of infective endocarditis. Emergency surgery for
left ventricular thrombus was considered necessary to pre-
vent thromboembolism.
At operation, the left ventricle was inspected through an
aortotomy and lateral left atriotomy. Gray, fragile, solid
masses were attached to the papillary muscles and left ven-
tricular endocardium (Figure 2, A and B). The aortic, mitral,
and tricuspid valves were not affected. The masses were
completely removed, and biopsy of the myocardium was
performed.
Pathologic examination revealed that the masses were
vegetations composed of organized thrombus, fibrin, and
proliferation of monocytes, compatible with a diagnosis
of Libman-Sacks endocarditis (Figure 2, C and D). The
specimen of the myocardium was indicative of myocarditis
with perivascular and interstitial invasion of monocytes.
The patient’s blood test results were positive for antinu-
clear, anti–double-strand DNA, and anti–cardiolipin b2
glycoprotein antibodies. These findings confirmed the
diagnosis of Libman-Sacks endocarditis and myocarditis
associated with systemic lupus erythematosus and antiphos-
pholipid antibody syndrome.
At 1 week after the operation, the patient began steroid
pulse therapy (methylprednisolone at 1 g/day). After 3months
of steroid therapy, her ejection fraction was improved to 50%rdiovascular Surgery c Volume 145, Number 2 e27
FIGURE 2. A and B, Intraoperative finding of vegetations (arrows) confined to the left ventricle. C, Gross specimen of resected vegetations. D, Pathologic
finding of organized thrombus, fibrin, and proliferation of monocytes.
Case Reportsand her New York Heart Association functional class was
improved to class I.
DISCUSSION
Myocarditis, characterized by perivascular and intersti-
tial invasion by lymphocytes and often associated with con-
gestive heart failure, is found in fewer than 10% of patients
with systemic lupus erythematosus.2 In Libman-Sacks en-
docarditis, the vegetations may appear as pea sized (3-4
mm), flat or slightly raised, granular, gray or pinkish projec-
tions, densely adherent to the endocardium and occurring
most frequently at the valve rings and commissures, spread-
ing over both valve surfaces, and even onto the atrial and
ventricular mural endocardium, chordae tendineae, and
papillary muscles. Libman-Sacks vegetations are micro-
scopically characterized by fibrin deposits of various stages
of fibroblastic organization and neovascularization and by
variable extents of inflammation with mononuclear cell in-
filtration. Vegetations are typically sessile, wartlike, and
small, varying from pinhead size to 3 to 4 mm, although in-
frequently they grow to 10 mm or even larger through the
formation of massive thrombotic lesions.3 Antiphospholi-
pid antibodies are thought to promote thrombus formation
on the endothelium of valves already compromised by
immune complex deposition, leading to further valvular
damage and inflammation.4 Ventricular vegetations in
Libman-Sacks endocarditis are quite rare. The mechanisme28 The Journal of Thoracic and Cardiovascular Surgof their formation is unclear; however, endothelial damage
or impaired left ventricular function may be a cause.
Most patients respond to high-dose corticosteroid ther-
apy, although some require the addition of the immuno-
suppressive agents. In our case, myocarditis responded
to high-dose corticosteroid therapy. Therapy with cortico-
steroids has been said to be associated with smaller and
fewer vegetations and to act in secondary prevention of sys-
temic embolism, but there is no evidence for this contention.
Fox and coworkers5 reported cases of systemic embolism
(brain, kidney, and spleen) from10-mmLibman-Sacksmitral
valve vegetations during the administration of high-dose
prednisone. Indication for resection might include vegeta-
tions that are larger than 10 mm or are mobile. Although
our patient responded to the steroid therapy and recovered
cardiac function, continuous follow-up is mandatory.
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